




















![]()
Q1: 2026-05-12 Earnings Summary
EPS of -$0.57 misses by $0.01
|
Revenue of
$0.00
beats by $0.00
Atea Pharmaceuticals, Inc. (AVIR) Q1 2026 Earnings Call May 12, 2026 4:30 PM EDT
Company Participants
Jonae Barnes - Senior Vice President of Investor Relations & Corporate Communications
Jean-Pierre Sommadossi - Founder, Chairman, CEO & President
Janet Hammond - Chief Development Officer
Maria Horga - Chief Medical Officer
John Vavricka - Chief Commercial Officer
Andrea Corcoran - CFO, Executive VP of Legal & Secretary
Conference Call Participants
Jonathan Miller - Evercore ISI Institutional Equities, Research Division
Selena Zhang - Morgan Stanley, Research Division
Tsan-Yu Hsieh - William Blair & Company L.L.C., Research Division
Presentation
Operator
Ladies and gentlemen, thank you for standing by. Welcome to Atea Pharmaceuticals First Quarter 2026 Earnings Conference Call. [Operator Instructions] I will now turn it over to the Atea's management team. Please go ahead.
Jonae Barnes
Senior Vice President of Investor Relations & Corporate Communications
Hi. Thank you, operator. Good afternoon, everyone, and welcome to Atea Pharmaceuticals' First Quarter 2026 Financial Results and Business Update Conference Call. Earlier today, we issued a press release, which outlines the topics we plan to discuss. You can access the press release as well as the slides that we'll be reviewing today by visiting the Investors section of our website at ir.ateapharma.com.
With me today from Atea are our Chief Executive Officer and Founder, Dr. Jean-Pierre Sommadossi; Chief Development Officer, Dr. Janet Hammond; Chief Commercial Officer, John Vavricka; Chief Medical Officer, Dr. Arantxa Horga; and Chief Financial Officer and Executive Vice President of Legal, Andrea Corcoran, who will all be available for the Q&A portion of today's call.
Before we begin the call, and as outlined on Slide 2, I would like to remind you that today's discussion will contain forward-looking statements that involve risks and uncertainties. These risks and uncertainties are outlined in today's press release and in the company's recent filings with the Securities and
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。